S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13

ShockWave Medical Stock Forecast, Price & News

+7.45 (+3.90%)
(As of 07/1/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
350,118 shs
Average Volume
543,614 shs
Market Capitalization
$7.11 billion
P/E Ratio
Dividend Yield
Price Target

ShockWave Medical Stock Forecast (MarketRank)

Analyst Rating
Moderate Buy
2.83 Rating Score
4.7% Upside
$207.86 Price Target
Short Interest
3.88% of Shares Sold Short
Dividend Strength
Upright™ Environmental Score
News Sentiment
0.45mentions of ShockWave Medical in the last 14 days
Based on 10 Articles This Week
Insider Trading
Selling Shares
$9.72 M Sold Last Quarter
Proj. Earnings Growth
From $1.84 to $2.82 Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

2.13 out of 5 stars

Medical Sector

327th out of 1,428 stocks

Surgical & Medical Instruments Industry

40th out of 137 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive SWAV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ShockWave Medical and its competitors with MarketBeat's FREE daily newsletter.

ShockWave Medical logo

About ShockWave Medical (NASDAQ:SWAV)

ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

SWAV Stock News Headlines

ShockWave Medical (NASDAQ:SWAV) Trading Down 7%
Why ShockWave Medical Dipped Today
ShockWave Medical (NASDAQ:SWAV) Shares Gap Up to $162.32
Why Sotera Health Stock Crushed the Market Today
See More Headlines

Industry, Sector and Symbol

Surgical & medical instruments
Current Symbol
Year Founded

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecasted Upside/Downside
Consensus Rating
Moderate Buy
Rating Score (0-4)
Research Coverage
6 Analysts


Net Income
$-9.14 million
Pretax Margin


Sales & Book Value

Annual Sales
$237.15 million
Book Value
$6.85 per share


Free Float
Market Cap
$7.11 billion
Not Optionable

ShockWave Medical Frequently Asked Questions

Should I buy or sell ShockWave Medical stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ShockWave Medical in the last twelve months. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" ShockWave Medical stock.
View analyst ratings for ShockWave Medical
or view top-rated stocks.

What is ShockWave Medical's stock price forecast for 2022?

6 Wall Street research analysts have issued 12 month target prices for ShockWave Medical's shares. Their SWAV stock forecasts range from $176.00 to $255.00. On average, they predict ShockWave Medical's share price to reach $207.86 in the next year. This suggests a possible upside of 4.7% from the stock's current price.
View analysts' price targets for ShockWave Medical
or view top-rated stocks among Wall Street analysts.

How has ShockWave Medical's stock price performed in 2022?

ShockWave Medical's stock was trading at $178.33 on January 1st, 2022. Since then, SWAV stock has increased by 11.4% and is now trading at $198.62.
View the best growth stocks for 2022 here

When is ShockWave Medical's next earnings date?

ShockWave Medical is scheduled to release its next quarterly earnings announcement on Monday, August 8th 2022.
View our earnings forecast for ShockWave Medical

How were ShockWave Medical's earnings last quarter?

ShockWave Medical, Inc. (NASDAQ:SWAV) announced its quarterly earnings results on Monday, May, 9th. The company reported $0.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.20. The business had revenue of $93.70 million for the quarter, compared to analysts' expectations of $86.41 million. ShockWave Medical had a net margin of 9.70% and a trailing twelve-month return on equity of 12.36%. The company's revenue was up 193.7% on a year-over-year basis. During the same quarter in the previous year, the company earned ($0.68) EPS.
View ShockWave Medical's earnings history

What guidance has ShockWave Medical issued on next quarter's earnings?

ShockWave Medical issued an update on its FY 2022 earnings guidance on Monday, June, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $435.00 million-$455.00 million, compared to the consensus revenue estimate of $417.90 million.

Who are ShockWave Medical's key executives?

ShockWave Medical's management team includes the following people:
  • Mr. Douglas E. Godshall M.B.A., Pres, CEO & Director (Age 57, Pay $1.4M)
  • Mr. Daniel Puckett MBA, CFO, Principal Financial Officer & Sec. (Age 58, Pay $658.71k)
  • Mr. Isaac Zacharias, Chief Commercial Officer (Age 47, Pay $679.54k) (LinkedIn Profile)
  • Mr. Daniel Hawkins, Founder and Sr. Advisor (Age 55)
  • Mr. John M. Adams, Co-Founder and Technical Advisor (Age 75)
  • Mr. Mike Maszy, VP of Operations
  • Ms. Trinh Phung, Chief Accounting Officer, Principal Accounting Officer & VP of Fin. (Age 44) (LinkedIn Profile)
  • Ms. Debbie Kaster, VP of Investor Relations
  • Mr. Hajime Tada J.D., Gen. Counsel & Sec.
  • Mr. Rob Williamson Jr., VP of Sales

What is Doug Godshall's approval rating as ShockWave Medical's CEO?

8 employees have rated ShockWave Medical CEO Doug Godshall on Glassdoor.com. Doug Godshall has an approval rating of 89% among ShockWave Medical's employees.

What other stocks do shareholders of ShockWave Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ShockWave Medical investors own include NVIDIA (NVDA), Walt Disney (DIS), Square (SQ), Trade Desk (TTD), Salesforce (CRM), Roku (ROKU), PayPal (PYPL), DexCom (DXCM), Alibaba Group (BABA) and Okta (OKTA).

When did ShockWave Medical IPO?

(SWAV) raised $75 million in an initial public offering on Thursday, March 7th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

What is ShockWave Medical's stock symbol?

ShockWave Medical trades on the NASDAQ under the ticker symbol "SWAV."

How do I buy shares of ShockWave Medical?

Shares of SWAV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ShockWave Medical's stock price today?

One share of SWAV stock can currently be purchased for approximately $198.62.

How much money does ShockWave Medical make?

ShockWave Medical (NASDAQ:SWAV) has a market capitalization of $7.11 billion and generates $237.15 million in revenue each year. The company earns $-9.14 million in net income (profit) each year or $0.77 on an earnings per share basis.

How many employees does ShockWave Medical have?

ShockWave Medical employs 657 workers across the globe.

How can I contact ShockWave Medical?

ShockWave Medical's mailing address is 5403 Betsy Ross Drive, Santa Clara CA, 95054. The official website for ShockWave Medical is www.shockwavemedical.com. The company can be reached via phone at (510) 279-4262 or via email at investors@shockwavemedical.com.

This page (NASDAQ:SWAV) was last updated on 7/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.